1. Home
  2. SLRX vs FICO Comparison

SLRX vs FICO Comparison

Compare SLRX & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • FICO
  • Stock Information
  • Founded
  • SLRX N/A
  • FICO 1956
  • Country
  • SLRX United States
  • FICO United States
  • Employees
  • SLRX N/A
  • FICO N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • FICO Business Services
  • Sector
  • SLRX Health Care
  • FICO Consumer Discretionary
  • Exchange
  • SLRX Nasdaq
  • FICO Nasdaq
  • Market Cap
  • SLRX 1.8M
  • FICO 44.2B
  • IPO Year
  • SLRX N/A
  • FICO 1987
  • Fundamental
  • Price
  • SLRX $0.89
  • FICO $1,852.00
  • Analyst Decision
  • SLRX
  • FICO Buy
  • Analyst Count
  • SLRX 0
  • FICO 12
  • Target Price
  • SLRX N/A
  • FICO $2,250.33
  • AVG Volume (30 Days)
  • SLRX 3.5M
  • FICO 226.2K
  • Earning Date
  • SLRX 08-08-2025
  • FICO 07-30-2025
  • Dividend Yield
  • SLRX N/A
  • FICO N/A
  • EPS Growth
  • SLRX N/A
  • FICO 21.78
  • EPS
  • SLRX N/A
  • FICO 23.21
  • Revenue
  • SLRX N/A
  • FICO $1,840,361,000.00
  • Revenue This Year
  • SLRX N/A
  • FICO $17.67
  • Revenue Next Year
  • SLRX N/A
  • FICO $15.78
  • P/E Ratio
  • SLRX N/A
  • FICO $79.93
  • Revenue Growth
  • SLRX N/A
  • FICO 14.71
  • 52 Week Low
  • SLRX $0.45
  • FICO $1,484.29
  • 52 Week High
  • SLRX $7.20
  • FICO $2,402.52
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 49.85
  • FICO 52.58
  • Support Level
  • SLRX $0.86
  • FICO $1,731.80
  • Resistance Level
  • SLRX $1.33
  • FICO $1,940.60
  • Average True Range (ATR)
  • SLRX 0.14
  • FICO 62.07
  • MACD
  • SLRX -0.01
  • FICO 8.81
  • Stochastic Oscillator
  • SLRX 38.70
  • FICO 59.19

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

Share on Social Networks: